BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Manganotti P, Bellavita G, D'Acunto L, Tommasini V, Fabris M, Sartori A, Bonzi L, Buoite Stella A, Pesavento V. Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain-Barré syndrome and polyneuritis cranialis in COVID-19 patients: A case series. J Med Virol 2021;93:766-74. [PMID: 32662899 DOI: 10.1002/jmv.26289] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Finsterer J, Scorza FA. Consider differentials before diagnosing SARS-CoV-2 associated Guillain-Barre syndrome. J Med Virol 2021;93:5246-7. [PMID: 33990971 DOI: 10.1002/jmv.27084] [Reference Citation Analysis]
2 Sandoval F, Julio K, Méndez G, Valderas C, Echeverría AC, Perinetti MJ, Suarez NM, Barraza G, Piñera C, Alarcón M, Samaniego F, Quesada-Rios P, Robles C, Izquierdo G. Neurologic Features Associated With SARS-CoV-2 Infection in Children: A Case Series Report. J Child Neurol 2021;:883073821989164. [PMID: 33646895 DOI: 10.1177/0883073821989164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Manganotti P, Bellavita G, D'Acunto L, Tommasini V, Fabris M, Sartori A, Bonzi L, Buoite Stella A, Pesavento V. Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain-Barré syndrome and polyneuritis cranialis in COVID-19 patients: A case series. J Med Virol 2021;93:766-74. [PMID: 32662899 DOI: 10.1002/jmv.26289] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 14.0] [Reference Citation Analysis]
4 Manganotti P, Buoite Stella A, Ajcevic M, di Girolamo FG, Biolo G, Franchi MV, Monti E, Sirago G, Marusic U, Simunic B, Narici MV, Pisot R. Peripheral nerve adaptations to 10 days of horizontal bed rest in healthy young adult males. Am J Physiol Regul Integr Comp Physiol 2021;321:R495-503. [PMID: 34318712 DOI: 10.1152/ajpregu.00146.2021] [Reference Citation Analysis]
5 Elzouki AN, Osman MAM, Ahmed MAE, Al-Abdulmalek A, Altermanini M, Al-Ani HA, Naeem M, Habas E. COVID-19 infection presented as Guillain-Barre Syndrome: Report of two new cases and review of 116 reported cases and case series. Travel Med Infect Dis 2021;44:102169. [PMID: 34624553 DOI: 10.1016/j.tmaid.2021.102169] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Akçay N, Menentoğlu ME, Bektaş G, Şevketoğlu E. Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child. J Med Virol 2021;93:5599-602. [PMID: 33851741 DOI: 10.1002/jmv.27018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Buoite Stella A, Furlanis G, Frezza NA, Valentinotti R, Ajcevic M, Manganotti P. Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study. J Neurol 2021. [PMID: 34386903 DOI: 10.1007/s00415-021-10735-y] [Reference Citation Analysis]
8 Cecchini MP, Brozzetti L, Cardobi N, Sacchetto L, Gibellini D, Montemezzi S, Cheli M, Manganotti P, Monaco S, Zanusso G. Persistent chemosensory dysfunction in a young patient with mild COVID-19 with partial recovery 15 months after the onset. Neurol Sci 2021. [PMID: 34601698 DOI: 10.1007/s10072-021-05635-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sullivan BN, Fischer T. Age-Associated Neurological Complications of COVID-19: A Systematic Review and Meta-Analysis. Front Aging Neurosci 2021;13:653694. [PMID: 34408638 DOI: 10.3389/fnagi.2021.653694] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ramos-Casals M, Brito-Zerón P, Mariette X. Systemic and organ-specific immune-related manifestations of COVID-19. Nat Rev Rheumatol 2021;17:315-32. [PMID: 33903743 DOI: 10.1038/s41584-021-00608-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
11 Avenali M, Martinelli D, Todisco M, Canavero I, Valentino F, Micieli G, Alfonsi E, Tassorelli C, Cosentino G. Clinical and Electrophysiological Outcome Measures of Patients With Post-Infectious Neurological Syndromes Related to COVID-19 Treated With Intensive Neurorehabilitation. Front Neurol 2021;12:643713. [PMID: 33776896 DOI: 10.3389/fneur.2021.643713] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
12 Manganotti P, Bellavita G, Tommasini V, D Acunto L, Fabris M, Cecotti L, Furlanis G, Sartori A, Bonzi L, Buoite Stella A, Pesavento V. Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID-19 neuropathy patients. J Med Virol 2021;93:5432-7. [PMID: 33951196 DOI: 10.1002/jmv.27061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Salari M, Zaker Harofteh B, Etemadifar M, Sedaghat N, Nouri H. Movement Disorders Associated with COVID-19. Parkinsons Dis 2021;2021:3227753. [PMID: 34790346 DOI: 10.1155/2021/3227753] [Reference Citation Analysis]
14 Palaiodimou L, Stefanou MI, Katsanos AH, Fragkou PC, Papadopoulou M, Moschovos C, Michopoulos I, Kokotis P, Bakirtzis C, Naska A, Vassilakopoulos TI, Chroni E, Tsiodras S, Tsivgoulis G. Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated with COVID-19: A systematic review and meta-analysis. Eur J Neurol 2021. [PMID: 33837630 DOI: 10.1111/ene.14860] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Nowak-Kiczmer M, Kubicka-Bączyk K, Niedziela N, Adamczyk B, Wierzbicki K, Bartman W, Adamczyk-Sowa M. The course of COVID-19 infection in patients with multiple sclerosis-The experience of one center based on the population of Upper Silesia. Mult Scler Relat Disord 2021;52:102984. [PMID: 34000683 DOI: 10.1016/j.msard.2021.102984] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Goudarzi S, Esmaeeli S, Valencia JD, Lu ME, Hales RR, Fehnel CR, Conley CM, Quraishi SA, Nozari A. Treatment Options for COVID-19-Related Guillain-Barré Syndrome: A Systematic Review of Literature. Neurologist 2021;26:196-224. [PMID: 34491938 DOI: 10.1097/NRL.0000000000000342] [Reference Citation Analysis]
17 Tawakul AA, Al-Doboke AW, Altayyar SA, Alsulami SA, Alfahmi AM, Nooh RT. Guillain-Barré Syndrome in the COVID-19 Pandemic. Neurol Int 2021;14:34-48. [PMID: 35076589 DOI: 10.3390/neurolint14010003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ariño H, Heartshorne R, Michael BD, Nicholson TR, Vincent A, Pollak TA, Vogrig A. Neuroimmune disorders in COVID-19. J Neurol 2022. [PMID: 35353232 DOI: 10.1007/s00415-022-11050-w] [Reference Citation Analysis]
19 Fredrich S, Greenberg BM, Hatanpaa KJ. Neurological infections in 2020: COVID-19 takes centre stage. Lancet Neurol 2021;20:17-8. [PMID: 33340476 DOI: 10.1016/S1474-4422(20)30451-8] [Reference Citation Analysis]
20 Hasan I, Saif‐ur‐rahman K, Hayat S, Papri N, Jahan I, Azam R, Ara G, Islam Z. Guillain‐Barré syndrome associated with SARS‐CoV ‐2 infection: A systematic review and individual participant data meta‐analysis. J Peripher Nerv Syst 2020;25:335-43. [DOI: 10.1111/jns.12419] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
21 Lima MA, Silva MTT, Soares CN, Coutinho R, Oliveira HS, Afonso L, Espíndola O, Leite AC, Araujo A. Peripheral facial nerve palsy associated with COVID-19. J Neurovirol 2020;26:941-4. [PMID: 33006717 DOI: 10.1007/s13365-020-00912-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 15.0] [Reference Citation Analysis]
22 Ganesh A, Reis IR, Varma M, Patry DG, Cooke LJ. Neurological and Head/Eyes/Ears/Nose/Throat Manifestations of COVID-19: A Systematic Review and Meta-Analysis. Can J Neurol Sci 2021;:1-18. [PMID: 34287109 DOI: 10.1017/cjn.2021.180] [Reference Citation Analysis]
23 Lewis A, Frontera J, Placantonakis DG, Galetta S, Balcer L, Melmed KR. Cerebrospinal fluid from COVID-19 patients with olfactory/gustatory dysfunction: A review. Clin Neurol Neurosurg 2021;207:106760. [PMID: 34146842 DOI: 10.1016/j.clineuro.2021.106760] [Reference Citation Analysis]
24 Abdullahi A, Candan SA, Soysal Tomruk M, Elibol N, Dada O, Truijen S, Saeys W. Is Guillain-Barré Syndrome Associated With COVID-19 Infection? A Systemic Review of the Evidence. Front Neurol 2020;11:566308. [PMID: 33519663 DOI: 10.3389/fneur.2020.566308] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Aladawi M, Elfil M, Abu-Esheh B, Abu Jazar D, Armouti A, Bayoumi A, Piccione E. Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review. Can J Neurol Sci 2021;:1-11. [PMID: 33949300 DOI: 10.1017/cjn.2021.102] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Chukhlovina ML. [Polyneuropathies during COVID-19 epidemics]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:138-43. [PMID: 34184490 DOI: 10.17116/jnevro2021121051138] [Reference Citation Analysis]
27 Ugbolue UC, Duclos M, Urzeala C, Berthon M, Kulik K, Bota A, Thivel D, Bagheri R, Gu Y, Baker JS, Andant N, Pereira B, Rouffiac K, Clinchamps M, Dutheil F, On Behalf Of The Covistress Network. An Assessment of the Novel COVISTRESS Questionnaire: COVID-19 Impact on Physical Activity, Sedentary Action and Psychological Emotion. J Clin Med 2020;9:E3352. [PMID: 33086648 DOI: 10.3390/jcm9103352] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
28 Podury S, Srivastava S, Khan E, Kakara M, Tandon M, Shrestha AK, Freeland K, Wen S, Sriwastava S. Relevance of CSF, Serum and Neuroimaging Markers in CNS and PNS Manifestation in COVID-19: A Systematic Review of Case Report and Case Series. Brain Sci 2021;11:1354. [PMID: 34679418 DOI: 10.3390/brainsci11101354] [Reference Citation Analysis]
29 Rahban M, Stanek A, Hooshmand A, Khamineh Y, Ahi S, Kazim SN, Ahmad F, Muronetz V, Samy Abousenna M, Zolghadri S, Saboury AA. Infection of Human Cells by SARS-CoV-2 and Molecular Overview of Gastrointestinal, Neurological, and Hepatic Problems in COVID-19 Patients. J Clin Med 2021;10:4802. [PMID: 34768321 DOI: 10.3390/jcm10214802] [Reference Citation Analysis]
30 Galassi G, Marchioni A. Acute neuromuscular syndromes with respiratory failure during COVID-19 pandemic: where we stand and challenges ahead. Journal of Clinical Neuroscience 2022. [DOI: 10.1016/j.jocn.2022.03.048] [Reference Citation Analysis]
31 Novelli L, Motta F, De Santis M, Ansari AA, Gershwin ME, Selmi C. The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature. J Autoimmun 2021;117:102592. [PMID: 33401171 DOI: 10.1016/j.jaut.2020.102592] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
32 Yazdanpanah N, Rezaei N. Autoimmune complications of COVID-19. J Med Virol 2021. [PMID: 34427929 DOI: 10.1002/jmv.27292] [Reference Citation Analysis]
33 Lewis A, Frontera J, Placantonakis DG, Lighter J, Galetta S, Balcer L, Melmed KR. Cerebrospinal fluid in COVID-19: A systematic review of the literature. J Neurol Sci 2021;421:117316. [PMID: 33561753 DOI: 10.1016/j.jns.2021.117316] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
34 Finsterer J, Scorza FA, Fiorini AC. SARS-CoV-2-associated Guillain-Barre syndrome in 62 patients. Eur J Neurol 2021;28:e10-2. [PMID: 32978857 DOI: 10.1111/ene.14544] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
35 Chan JL, Murphy KA, Sarna JR. Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review. J Neurol 2021. [PMID: 33616739 DOI: 10.1007/s00415-021-10458-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
36 Ergin Beton O, Ozturk Tan O, Bilen S. The potential association between COVID-19 disease and Guillain-Barré syndrome. Neurol Res 2022;:1-6. [PMID: 35348038 DOI: 10.1080/01616412.2022.2056342] [Reference Citation Analysis]
37 Johansson A, Mohamed MS, Moulin TC, Schiöth HB. Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms. J Neuroimmunol 2021;358:577658. [PMID: 34304141 DOI: 10.1016/j.jneuroim.2021.577658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Tekin AB, Zanapalioglu U, Gulmez S, Akarsu I, Yassa M, Tug N. Guillain Barre Syndrome following delivery in a pregnant woman infected with SARS-CoV-2. J Clin Neurosci 2021;86:190-2. [PMID: 33775326 DOI: 10.1016/j.jocn.2021.01.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
39 Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol 2021;268:1133-70. [PMID: 32840686 DOI: 10.1007/s00415-020-10124-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 28.0] [Reference Citation Analysis]
40 Ousseiran ZH, Fares Y, Chamoun WT. Neurological manifestations of COVID-19: a systematic review and detailed comprehension. Int J Neurosci 2021;:1-16. [PMID: 34433369 DOI: 10.1080/00207454.2021.1973000] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Freire M, Andrade A, Sopeña B, Lopez-Rodriguez M, Varela P, Cacabelos P, Esteban H, González-Quintela A. Guillain Barré syndrome associated with COVID-19- lessons learned about its pathogenesis during the first year of the pandemic, a systematic review. Autoimmun Rev 2021;20:102875. [PMID: 34119673 DOI: 10.1016/j.autrev.2021.102875] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Manganotti P, Furlanis G, Ajčević M, Moras C, Bonzi L, Pesavento V, Buoite Stella A. Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients. J Neurol 2021. [PMID: 33709220 DOI: 10.1007/s00415-021-10468-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]